Cargando…

Epidemiology and Clinical Outcomes of Non-HACEK Gram-Negative Infective Endocarditis

BACKGROUND: The objectives of this study were to describe the changing epidemiology of gram-negative infective endocarditis (GNIE) and to identify factors associated with treatment failure and death. METHODS: Adult patients with GNIE were included if they met modified Duke criteria for definitive in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shah, Sunish, Clarke, Lloyd G, Shields, Ryan K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034592/ https://www.ncbi.nlm.nih.gov/pubmed/36968963 http://dx.doi.org/10.1093/ofid/ofad052

Ejemplares similares

Epidemiology and outcomes of non-HACEK infective endocarditis in the southeast United States
por: Veve, Michael P., et al.
Publicado: (2020)

Infective endocarditis by HACEK: a review
por: Khaledi, Mansoor, et al.
Publicado: (2022)

Native Mitral Valve Endocarditis Caused by a Non-HACEK Gram-Negative Pathogen in a Hemodialysis Patient
por: Imeri, Ilire, et al.
Publicado: (2023)

2410. Clinical outcomes and antimicrobial management strategies of Pseudomonas endocarditis
por: Shah, Sunish, et al.
Publicado: (2023)

Infective Endocarditis due to Non-HACEK Gram-Negative Bacilli: Clinical Characteristics and Risk Factors from a Prospective Multicenter Brazilian Cohort
por: de Sousa, Leonardo Paiva, et al.
Publicado: (2023)

Epidemiology, bacteriology, and clinical characteristics of HACEK bacteremia and endocarditis: a population-based retrospective study
por: Berge, Andreas, et al.
Publicado: (2020)

HACEK Infective Endocarditis: Characteristics and Outcomes from a Large, Multi-National Cohort
por: Chambers, Stephen T., et al.
Publicado: (2013)

Infective endocarditis caused by HACEK group bacteria—a registry-based comparative study
por: Bläckberg, Anna, et al.
Publicado: (2021)

Prosthetic Valve Endocarditis caused by HACEK Organisms: a Case Report and Systematic Review of the Literature
por: Choi, Ha Na, et al.
Publicado: (2017)

Epidemiology of Gram-Negative Bloodstream Infections in the United States: Results From a Cohort of 24 Hospitals
por: Ince, Dilek, et al.
Publicado: (2023)

Clinical Outcomes With Extended Versus Intermittent Infusion of Anti-Pseudomonal Beta-Lactams in Patients With Gram-Negative Bacteremia
por: Tran, Nikki N, et al.
Publicado: (2023)

Impact of Catheter Management on Clinical Outcome in Adult Cancer Patients With Gram-Negative Bacteremia
por: Fares, Johny, et al.
Publicado: (2019)

In Vitro Activity of Essential Oils Against Gram-Positive and Gram-Negative Clinical Isolates, Including Carbapenem-Resistant Enterobacteriaceae
por: Patterson, Jan E, et al.
Publicado: (2019)

2775. Clinical Outcomes and Treatment-Emergent Resistance of Piperacillin-tazobactam, Cefepime, Carbapenems and Fluoroquinolones for the Treatment of Bloodstream Infections due to AmpC β-Lactamase-Producing Enterobacterales
por: Jawanda, Jasanjeet, et al.
Publicado: (2023)

Is It Actionable? An Evaluation of the Rapid PCR-Based Blood Culture Identification Panel on the Management of Gram-Positive and Gram-Negative Blood Stream Infections
por: Tseng, Andrew S, et al.
Publicado: (2018)

Impact of Setting up an “Endocarditis Team” on the Management of Infective Endocarditis
por: Ruch, Yvon, et al.
Publicado: (2019)

Real-World Experience With Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections
por: Jorgensen, Sarah C J, et al.
Publicado: (2019)

Risk of Cardiovascular Implantable Electronic Device Infection in Patients Presenting With Gram-Negative Bacteremia
por: Chesdachai, Supavit, et al.
Publicado: (2022)

A Desirability of Outcome Ranking Analysis of a Randomized Clinical Trial Comparing Seven Versus Fourteen Days of Antibiotics for Uncomplicated Gram-Negative Bloodstream Infection
por: Howard-Anderson, Jessica, et al.
Publicado: (2022)

Impact of a Multistep Bundles Intervention in the Management and Outcome of Gram-Negative Bloodstream Infections: A Single-Center “Proof-of-Concept” Study
por: Bavaro, Davide Fiore, et al.
Publicado: (2022)

Clinical Features and Outcomes of Streptococcus anginosus Group Infective Endocarditis: A Multicenter Matched Cohort Study
por: Escrihuela-Vidal, Francesc, et al.
Publicado: (2021)

Impact of an Antimicrobial Stewardship Bundle for Uncomplicated Gram-Negative Bacteremia
por: Erickson, Reaghan M, et al.
Publicado: (2019)

The Impact of Acute Kidney Injury on the Risk of Mortality and Health Care Utilization Among Patients Treated With Polymyxins for Severe Gram-Negative Infections
por: Baradaran, Sarah, et al.
Publicado: (2018)

Prevalence of Carbapenem-Resistant Gram-Negative Infections in the United States Predominated by Acinetobacter baumannii and Pseudomonas aeruginosa
por: Cai, Bin, et al.
Publicado: (2017)

Management of Gram-Negative Bloodstream Infections in the Era of Rapid Diagnostic Testing: Impact With and Without Antibiotic Stewardship
por: Claeys, Kimberly C, et al.
Publicado: (2020)

Prognostic Utility of the New Definition of Difficult-to-Treat Resistance Among Patients With Gram-Negative Bloodstream Infections
por: Giannella, Maddalena, et al.
Publicado: (2019)

Infective Endocarditis Due to Corynebacterium Species: Clinical Features and Antibiotic Resistance
por: Bläckberg, Anna, et al.
Publicado: (2021)

Risk Factors for Development of Carbapenem Resistance Among Gram-Negative Rods
por: Richter, Stefan E, et al.
Publicado: (2019)

Optimizing the Management of Uncomplicated Gram-Negative Bloodstream Infections: Consensus Guidance Using a Modified Delphi Process
por: Heil, Emily L, et al.
Publicado: (2021)

Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa
por: Alosaimy, Sara, et al.
Publicado: (2021)

Carbapenem-Nonsusceptible Gram-Negative Pathogens in ICU and Non-ICU Settings in US Hospitals in 2017: A Multicenter Study
por: McCann, Eilish, et al.
Publicado: (2018)

Stewardship-Guided T2Candida Testing Shortens Time to Antifungal Treatment and Reduces Antifungal Usage Among Medical Intensive Care Unit Patients With Septic Shock
por: O’Donnell, Matthew, et al.
Publicado: (2023)

1044. Aztreonam (AZT) vs. Cephalosporin (CEP) Therapy for the Treatment of Gram-Negative Bacteremia
por: Shah, Sunish, et al.
Publicado: (2018)

Patterns, Predictors, and Intercenter Variability in Empiric Gram-Negative Antibiotic Use Across 928 United States Hospitals
por: Goodman, Katherine E, et al.
Publicado: (2022)

Beta-Hemolytic Streptococcal Infective Endocarditis: Characteristics and Outcomes From a Large, Multinational Cohort
por: Fernández Hidalgo, Núria, et al.
Publicado: (2020)

Outcomes and Risk Factors of Septic Shock in Patients With Infective Endocarditis: A Prospective Cohort Study
por: Pericàs, Juan M, et al.
Publicado: (2021)

Outcomes of Endocarditis in Pregnancy: A Single-Center Experience
por: Shapero, Kayle, et al.
Publicado: (2023)

Predictors of Surgical Intervention in Dialysis Patients With Infective Endocarditis
por: Woller III, John A, et al.
Publicado: (2018)

Recurrent Endocarditis in Persons Who Inject Drugs
por: Rodger, Laura, et al.
Publicado: (2019)

144. Impact of Rapid Identification and Resistance Gene Detection using an Algorithm-Based Approach in Gram-Negative Bacteremia
por: Jawanda, Jasanjeet, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r0lf5flv6gp1q4hjhdejaaimkq